Top Markets
Coin of the day
GeneDx Holdings Corp. GeneDx Holdings Corp.

GeneDx Holdings Corp.

WGS
Classement en actions #5446
GeneDx Holdings Corp. functions as a health intelligence firm singularly... GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
Prix de l'action
$90.29
Dernière synchronisation: 2026-08-26
Capitalisation boursière
$2.69B
Changement (1 jour)
3.30%
Changement (1 an)
-30.11%
Pays
US
Échange GeneDx Holdings Corp. (WGS)

Catégorie

Ratio P/B pour GeneDx Holdings Corp. (WGS)
Ratio P/B au 2026 TTM : 0
Selon les derniers rapports financiers et le cours de l'action de GeneDx Holdings Corp., le ratio cours/valeur comptable actuel (TTM) est 0. À la fin de 2026, le ratio P/B était de 0.
Historique du ratio P/B pour GeneDx Holdings Corp. de 2026 à 2026
Ratio P/B à la fin de chaque année
Année Ratio P/B Changez
Pas assez de données pour les dates fournies.
Ratio P/B pour des entreprises similaires ou concurrentes
Entreprise Ratio P/B Différence de Ratio P/B Pays
3.0416 -
US
48.0487 -
AU
21.0676 -
US
6.2063 -
US
- -
US